Related Experiment Video
Updated: Sep 20, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections
Rafael Pellegrino1, Umberto Galvalisi, Paola Scavone
1Laboratorio de Microbiología, Instituto de Investigaciones Biológicas Clemente Estable, Av. Italia 3318, P.O. Box 11600, Montevideo, Uruguay.
Abstract:
Proteus mirabilis is a common cause of urinary tract infection (UTI) and produce several types of different fimbriae, including mannose-resistant/Proteus-like fimbriae, uroepithelial cell adhesin (UCA), and P. mirabilis fimbriae (PMF). Different authors have related these fimbriae with different aspects of P. mirabilis pathogenesis, although the precise role of fimbriae in UTI has not yet been elucidated. In this work we expressed and purified recombinant structural fimbrial proteins of these fimbriae (MrpA, UcaA, and PmfA) and assessed their role as protective antigens using an ascending and a haematogenous model of UTI in the mouse. MrpA protected subcutaneously immunised mice in both models, suggesting that it could be taken into account as a promising vaccine candidate against P. mirabilis UTI. UcaA could also be an interesting subunit to be studied although it only protected mice that were challenged intravenously. All subunits elicited a strong specific serum IgG response but there was no significant correlation between antibody levels and protection. Only PmfA-immunised mice elicited a significant urinary antibody response but this protein was unable to confer protection against P. mirabilis experimental challenges. These results may contribute to the development of vaccines against P. mirabilis, an important cause of complicated UTI.
Insights
Proteus mirabilis fimbrial proteins were evaluated as vaccine candidates against urinary tract infections (UTIs). MrpA demonstrated significant protection in mouse models, highlighting its potential for UTI vaccine development.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Proteus mirabilis is a significant cause of urinary tract infections (UTIs).
- Fimbriae play a role in P. mirabilis pathogenesis, but their precise function in UTIs remains unclear.
- Key fimbrial proteins include mannose-resistant/Proteus-like (MrpA), uroepithelial cell adhesin (UcaA), and P. mirabilis fimbriae (PmfA).
Purpose of the Study:
- To assess the protective potential of recombinant MrpA, UcaA, and PmfA as vaccine candidates against P. mirabilis UTIs.
- To investigate the correlation between antibody responses and protection in experimental UTI models.
Main Methods:
- Expression and purification of recombinant fimbrial proteins: MrpA, UcaA, and PmfA.
- Immunization of mice with purified proteins.
- Challenge experiments using ascending and hematogenous models of UTI.
- Measurement of specific serum and urinary antibody responses.
Main Results:
- MrpA conferred significant protection in both ascending and hematogenous UTI models, indicating its promise as a vaccine candidate.
- UcaA provided protection only in the hematogenous model.
- All tested proteins induced strong serum IgG responses, but antibody levels did not correlate with protection.
- PmfA induced a significant urinary antibody response but failed to protect against infection.
Conclusions:
- MrpA is a promising vaccine candidate for preventing P. mirabilis UTIs.
- UcaA warrants further investigation for its potential role in UTI pathogenesis and prevention.
- Fimbrial antigenicity does not directly correlate with protective immunity against P. mirabilis UTIs.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
Fimbriae, Pili, and Axial Filaments
Microbiota of the Urogenital Tract

